ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1402

Meeting the Needs of Adolescents with Autoimmune Diseases, the Development of a Clinical Transition Pathway

Margot Walter1, Johanna M.W. Hazes2, Radboud JEM Dolhain3, Philomine A. van Pelt4, A. Dijk van5 and Sylvia S.M. Kamphuis6, 1Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, 2Department of Rheumatology, Erasmus University Medical Centre, Rotterdam, Netherlands, 3Rheumatology, University Medical Center Rotterdam, Rotterdam, Netherlands, 4Rheumatology, Erasmus MC, Rotterdam, Netherlands, 5Sophia Children's Hospital, Erasmusmc, Rotterdam, Netherlands, 6Pediatric Rheumatology, Sophia Children's Hospital – Erasmus University Medical Centre, Rotterdam, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Adolescence and Transition

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects - ARHP Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Evidence based recommendations for transitional programs are available. Despite this, half of Young People (YP) do not make a successful transfer and implementation of transitional care is not widespread. Therefore, it is important to improve transitional care for YP with an autoimmune disease (AID). A potential tool could be the institution of a clinical transition pathway (CTP). The aim of this study was i) to explore how YP with an AID and their parent(s) experience care during the preparation for the upcoming transfer to adult care, ii) to develop a CTP.  

Methods: A survey was conducted among YP with an AID (n=48), age 14-20 years with a separate survey for parents (n=48). Subjects of the 38 survey-questions involved demographics, achievement of self-management skills, experience with preparation for transfer and questioning for topics that were not discussed but should have been in clinic. The CTP was built based on principles of vanHaecht & Sermeus¹, results of the surveys were incorporated into the CTP.

Results: Response rate was 67% for YP and 69% for parents. It appeared that almost all YP attended the consultation with  parents (88%). Training self-management skills was neglected and only 25% of YP were ordering medication or made appointments independently (15 %). Transition was not a topic in the consultation according to half of the YP. One third of all parents had feelings of anxiety about the upcoming transfer. Almost half of the YP needed discussing topics that were never mentioned during consultation like education, vocational, and alcohol. Results were used to built the CTP (figure 1). Most important points are an early start , with focus on self-management skills and independency using an individual transition plan (ITP) for each patient, joint consultations with professionals from both pediatric and adult rheumatology departments and supporting parents in letting go. The ITP (developed using ‘DREAM TEAM UK’ ²) was divided into 3 age-categories (12-14;14-16;16-18+), with final checklist regarding different domains and per category targets that needed to be met. 

Conclusion:  Current care in general does not meet the needs of YP  in the process of transition to adult rheumatology care.  The developed CTP is a tool to improve this process with provision of care appropriate to the developmental stage of YP, focus on achievement of self-management skills and self-reliance and supporting parents during this process. ¹ VanHaecht et all. Clinical pathway audit tools: a systematic review. Journal of Nursing Management, 2006, 14, 529–537K. ² McDonagh et all. Growing up and moving on in rheumatology: development and preliminary evaluation of a transitional care programme for a multicentre cohort of adolescents with juvenile idiopathic arthritis J Child Health Care. 2006 Mar;10(1):22-42.   


Disclosure: M. Walter, None; J. M. W. Hazes, None; R. J. Dolhain, None; P. A. van Pelt, None; A. Dijk van, None; S. S. M. Kamphuis, None.

To cite this abstract in AMA style:

Walter M, Hazes JMW, Dolhain RJ, van Pelt PA, Dijk van A, Kamphuis SSM. Meeting the Needs of Adolescents with Autoimmune Diseases, the Development of a Clinical Transition Pathway [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/meeting-the-needs-of-adolescents-with-autoimmune-diseases-the-development-of-a-clinical-transition-pathway/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/meeting-the-needs-of-adolescents-with-autoimmune-diseases-the-development-of-a-clinical-transition-pathway/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology